Actinium Pharmaceuticals Inc (AMEX: ATNM) Now Carries A 12-Month Price Target Of $4.95.
Actinium Pharmaceuticals Inc (AMEX:ATNM)’s traded shares stood at 0.45 million during the last session, with the company’s beta value hitting 0.14. At the close of